Clover Health targets Adjusted EBITDA profitability for full-year 2024

CLOVER HEALTH INVESTMENTS, CORP. /DE

Targets Adjusted EBITDA profitability for full-year 2024.
CEO Andrew Toy cites strong 2023 Insurance performance and Clover Assistant technology.
Plans to focus on member retention rather than expansion in core markets.
Will issue full-year 2024 guidance at a later date.
Presentation at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.